Literature DB >> 24715451

Musculoskeletal applications of PET/MR.

In Sook Lee1, Yoo Hye Jin2, Sung Hwan Hong2, Seoung-Oh Yang3.   

Abstract

To overcome each limitation of morphological and functional imaging procedures, hybrid imaging systems have been developed and introduced into clinical routine. It has been increasingly discussed whether magnetic resonance imaging (MRI) might be an appropriate alternative for computed tomography (CT). The major advantage of positron emission tomography (PET)/MR consists of combined metabolic and anatomical information in a single imaging session that provides superior soft tissue characterization of MRI over CT. Until now, fusion image has been effectively utilized in oncologic indications. Because biopsy cannot be replaced by images for definite diagnosis, fusion imaging may be more efficient for staging based on nodal spread or metastases rather than the diagnosis of primary tumor, and it can be proficient for treatment response or postoperative assessment. This review describes mainly oncologic and nontumorous conditions among the musculoskeletal applications of PET/MR. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 24715451     DOI: 10.1055/s-0034-1371021

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  4 in total

1.  [MRI/PET for the detection of bone metastases. The new gold standard?].

Authors:  M-A Weber
Journal:  Radiologe       Date:  2015-09       Impact factor: 0.635

Review 2.  Utility of positron emission tomography-magnetic resonance imaging in musculoskeletal imaging.

Authors:  Ammar A Chaudhry; Maryam Gul; Elaine Gould; Mathew Teng; Kevin Baker; Robert Matthews
Journal:  World J Radiol       Date:  2016-03-28

3.  PET/MRI of metabolic activity in osteoarthritis: A feasibility study.

Authors:  Feliks Kogan; Audrey P Fan; Emily J McWalter; Edwin H G Oei; Andrew Quon; Garry E Gold
Journal:  J Magn Reson Imaging       Date:  2016-10-31       Impact factor: 4.813

Review 4.  Melanoma & nuclear medicine: new insights & advances.

Authors:  Andrés Perissinotti; Daphne Dd Rietbergen; Sergi Vidal-Sicart; Ana A Riera; Renato A Valdés Olmos
Journal:  Melanoma Manag       Date:  2018-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.